AMCP Nexus

In a session presented at the AMCP Nexus 2023 conference in Orlando, Adam Colborn, JD, director of Government Relations at AMCP, discussed how the recent ERISA preemption rule influenced employer pharmacy benefits, and also highlighted a policy that hasn't received much attention in the managed care pharmacy space: California's CalRx Biosimilar Insulin Initiative.

Adam Colborn, JD, director of Government Relations at AMCP, addressed topics at this year's AMCP Nexus conference in Orlando such as transparency, cost sharing mandates and variables that affect the supply and demand curve for pharmaceuticals within legislation at a federal, but mainly state level. Colborn also touched on the large PBM reform regulation happening currently in New York as it could be a model that other states can follow.

Attendance rebounded to pre-pandemic levels at the AMCP Nexus 2022 meeting in National Harbor, Maryland, and very few attendees worse masks.

Kelly Price, vice president of market access for Mahana Therapeutics, compared the difference between digital therapeutics, prescription digital therapeutics and how FDA approval factors into that difference. She also shared what's hopeful and what's to come as far as coverage decisions, rule changes and FDA guidance for digital therapeutics in 2023.

Kevin Astle, Pharm.D., discussed on-demand HIV preexposure prophylaxis (PrEP), the advent of long-term injectables, and updated CDC guidelines at the AMCP Nexus 2022 meeting in National Harbor, Maryland.